日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Higher Absolute Lymphocyte Counts and Lower Des-γ-Carboxyprothrombin Levels After Treatment Initiation Are Associated With the Clinical Efficacy of Tremelimumab Plus Durvalumab Combination Therapy for Hepatocellular Carcinoma

治疗开始后较高的绝对淋巴细胞计数和较低的去羧基凝血酶原水平与曲美利单抗联合度伐利尤单抗治疗肝细胞癌的临床疗效相关。

Inoue, Yuta; Yano, Yoshihiko; Kushida, Saeko; Hirohata, Seiya; Yoon, Seitetsu; Yasutomi, Eiichiro; Hirano, Hirotaka; Kim, Soo Ki; Yoshida, Ryutaro; Ueda, Yoshihide; Momose, Kenji; Hayashi, Hiroki; Kado, Takuo; Nishi, Katsuhisa; Tanaka, Hidenori; Matono, Tomomitsu; Yamamoto, Atsushi; Tei, Hiroshi; Nishioka, Chiharu; Yagi, Yosuke; Tamura, Shoji; Sakane, Tatsuya; Ehara, Mayumi; Kawano, Miki; Kitadai, Jun; Matsuura, Takanori; Shiomi, Yuuki; Komatsu, Shohei; Fukumoto, Takumi; Tada, Toshifumi; Kodama, Yuzo

A Case of Advanced Renal Cell Carcinoma With Concomitant Development of Multiple Endocrine Neoplasia Type 1 That Affected Treatment Progress With Immunotherapy

一例晚期肾细胞癌合并1型多发性内分泌肿瘤,影响免疫治疗进展的病例报告

Abe, Masataka; Miyaji, Yoshiyuki; Sugiyama, Seitetsu; Tsurui, Kiwami; Morinaka, Hirofumi; Kaifu, Mikako; Kadoya, Hiroyuki; Saito, Wataru; Yoshida, Koji; Komura, Kazumasa

Factors associated with the response to atezolizumab/bevacizumab combination therapy for hepatocellular carcinoma

影响肝细胞癌对阿特珠单抗/贝伐珠单抗联合治疗反应的因素

Yano, Yoshihiko; Yamamoto, Atsushi; Mimura, Takuya; Kushida, Saeko; Hirohata, Seiya; Yoon, Seitetsu; Hirano, Hirotaka; Kim, Soo Ki; Hatazawa, Yuri; Momose, Kenji; Hayashi, Hiroki; Kado, Takuo; Nishi, Katsuhisa; Tanaka, Hidenori; Matsuura, Takanori; Yoshida, Ryutaro; Asaji, Naoki; Yasutomi, Eiichiro; Shiomi, Yuuki; Minami, Akihiro; Komatsu, Shohei; Fukumoto, Takumi; Ueda, Yoshihide; Kodama, Yuzo

Primary Presacral Neuroendocrine Tumor Presenting as Multiple Liver Metastasis: A Case Report

原发性骶前神经内分泌肿瘤以多发性肝转移为首发表现:病例报告

Watanabe, Takafumi; Yoon, Seitetsu; Yamakawa, Kohei; Hyodo, Toshiki; Izaki, Kenta; Okada, Hirofumi; Shirakawa, Yutaka; Ebisutani, Chikara; Sakamoto, Yoshio; Hirohata, Shigeya

Significance of post-progression therapy after tyrosine kinase inhibitors for advanced hepatocellular carcinoma

酪氨酸激酶抑制剂治疗晚期肝细胞癌后进展治疗的意义

Yano, Yoshihiko; Yamamoto, Atsushi; Minami, Akihiro; Momose, Kenji; Mimura, Takuya; Kim, Soo Ki; Hayashi, Hiroki; Kado, Takuo; Hirano, Hirotaka; Hirohata, Seiya; Yoon, Seitetsu; Nishi, Katsuhisa; Tei, Hiroshi; Tanaka, Hidenori; Oouchi, Sachiko; Matsuura, Takanori; Yasutomi, Eiichiro; Hatazawa, Yuri; Shiomi, Yuuki; Ueda, Yoshihide; Kodama, Yuzo

Factors associated with the decrease in hepatitis B surface antigen titers following interferon therapy in patients with chronic hepatitis B: Is interferon and adefovir combination therapy effective?

慢性乙型肝炎患者接受干扰素治疗后乙型肝炎表面抗原滴度下降的相关因素:干扰素和阿德福韦联合治疗是否有效?

Yano, Yoshihiko; Seo, Yasushi; Hayashi, Hiroki; Hatazawa, Yuri; Hirano, Hirotaka; Minami, Akihiro; Kawano, Yuki; Saito, Masaya; Ninomiya, Toshiaki; Sugano, Masahiko; Yamada, Hajime; Kitajima, Naoto; Yoon, Seitetsu; Hayashi, Yoshitake

Early Postoperative Outcome of Off-Pump Coronary Artery Bypass Grafting: A Report from the Highest-Volume Center in Japan

日本最高手术量中心报告的非体外循环冠状动脉旁路移植术早期术后结果

Kuroda, Kishio; Kato, Tomoko S; Kuwaki, Kenji; Kajimoto, Kan; Lee, Seitetsu L; Yamamoto, Taira; Amano, Atsushi